CETUXIMAB

UNII:	PQX0D8J21J
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	CETUXIMAB
GSRS Full Record:	PQX0D8J21J i

205923-56-4
ABP-494
C-225
C225
CETUXIMAB (GENETICAL RECOMBINATION)
CETUXIMAB (GENETICAL RECOMBINATION) [JAN]
CETUXIMAB BIOSIMILAR (ABP-494)
CETUXIMAB BIOSIMILAR (SHANGHAI ZHANGJIANG)
CETUXIMAB [EMA EPAR]
CETUXIMAB [HSDB]
CETUXIMAB [JAN]
CETUXIMAB [MART.]
CETUXIMAB [MI]
CETUXIMAB [PURPLE BOOK CDER]
CETUXIMAB [USAN]
CETUXIMAB [VANDF]
CMAB-009
CMAB-009 (BIOSIMILAR OF CETUXIMAB)
CMAB009
Cetuximab
Cetuximab Beta
Cetuximab [WHO-DD]
Cetuximab beta [WHO-DD]
ERBITUX
EXTRACELLULAR DOMAIN HUMAN EGFR BINDING RECOMBINANT, HUMAN/MOUSE CHIMERIC MONOCLONAL ANTIBODY
FV REGIONS OF MURINE ANTI-EGFR ANTIBODY WITH HUMAN IGG1 HEAVY AND KAPPA LIGHT CHAIN CONSTANT REGIONS, MW 152000
IMC-225
IMC-C225
IMCC-225
IMCC225
Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 γ1-chain), disulfide with human-mouse monoclonal C225 κ-chain, dimer
MOAB C225
cetuximab [INN]
cetuximab beta [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CETUXIMAB

Synonyms and Mappings

Resources